Practice Changing Publications: Expert Panel Discussion 08-29-2023
Publication/Article
Nonablative Fractional Laser Treatment Is Associated With a Decreased Risk of Subsequent Facial Keratinocyte Carcinoma Development
Citation: Benson T.A., Hibler B.P., Kotliar D, Avram M. Nonablative Fractional Laser Treatment Is Associated With a Decreased Risk of Subsequent Facial Keratinocyte Carcinoma Development. Dermatol Surg. 2023 Feb;49(2):149-154
Date/Time
Tuesday, August 29, 2023 | 7:00-8:00 pm Central
Description
This webinar will review the findings published from a study conducted at Massachusetts General Hospital Dermatology Laser and Cosmetic Center between 2005 and 2021, analyzing the use of non-ablative fractional laser treatment in decreasing the risk of keratinocyte carcinoma development. The session will start with a summary of the key findings from this retrospective cohort study, followed by an expert panel discussion of the publication.
Learning Objectives
Following this activity, participants should be able to:
CME: 1.00 AMA PRA Category 1 Credit™
To obtain CME credit in your ASDS Learn profile and download your CME certificate, you will need to view the webinar and complete the attendee evaluation. Credit is provided for live webinar attendees.
Accreditation Statement
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nonablative Fractional Laser Treatment Is Associated With a Decreased Risk of Subsequent Facial Keratinocyte Carcinoma Development
Citation: Benson T.A., Hibler B.P., Kotliar D, Avram M. Nonablative Fractional Laser Treatment Is Associated With a Decreased Risk of Subsequent Facial Keratinocyte Carcinoma Development. Dermatol Surg. 2023 Feb;49(2):149-154
Date/Time
Tuesday, August 29, 2023 | 7:00-8:00 pm Central
Description
This webinar will review the findings published from a study conducted at Massachusetts General Hospital Dermatology Laser and Cosmetic Center between 2005 and 2021, analyzing the use of non-ablative fractional laser treatment in decreasing the risk of keratinocyte carcinoma development. The session will start with a summary of the key findings from this retrospective cohort study, followed by an expert panel discussion of the publication.
Learning Objectives
Following this activity, participants should be able to:
- Discuss the potential role for non-ablative fractional laser in keratinocyte carcinoma prophylaxis in patients with a history of keratinocyte carcinoma.
- Recognize the potential benefits and risks associated with non-ablative fractional laser compared to alternative treatment methods for keratinocyte carcinoma prophylaxis.
- Describe a plausible biological mechanism in which non-ablative fractional laser may prevent keratinocyte carcinoma development.
CME: 1.00 AMA PRA Category 1 Credit™
To obtain CME credit in your ASDS Learn profile and download your CME certificate, you will need to view the webinar and complete the attendee evaluation. Credit is provided for live webinar attendees.
Accreditation Statement
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presenters
Mathew Avram, MD, JD
Faculty / Author
Dr. Avram is a board-certified dermatologist, and serves as Director of Mass General Dermatology Laser & Cosmetic Center and Dermatologic Surgery at MGH, Faculty Director for Procedural Training in the Department of Dermatology and Associate Professor of Dermatology at Harvard Medical School and Co-Director of the MGH/Wellman Laser & Cosmetic Fellowship.
Faculty / Author
Dr. Avram is a board-certified dermatologist, and serves as Director of Mass General Dermatology Laser & Cosmetic Center and Dermatologic Surgery at MGH, Faculty Director for Procedural Training in the Department of Dermatology and Associate Professor of Dermatology at Harvard Medical School and Co-Director of the MGH/Wellman Laser & Cosmetic Fellowship.
Travis Benson, MD
Faculty / Author
Dr. Benson is a PGY-2 dermatology resident at University of Pennsylvania. Dr. Benson is a contributing author to four research publications since 2019 and has worked as a Research Assistant at both Boston Children’s Hospital and Brigham and Women’s Hospital.
Faculty / Author
Dr. Benson is a PGY-2 dermatology resident at University of Pennsylvania. Dr. Benson is a contributing author to four research publications since 2019 and has worked as a Research Assistant at both Boston Children’s Hospital and Brigham and Women’s Hospital.
Macrene Alexiades, MD, PhD
Faculty / Panelist
Dr. Alexiades is a board-certified dermatologist, three-time Harvard graduate with a BA in Biology, MD and PhD in Genetics, and currently serves as Associate Clinical Professor at Yale University and Adjunct Professor at Sigros Hospital, University of Athens.
Faculty / Panelist
Dr. Alexiades is a board-certified dermatologist, three-time Harvard graduate with a BA in Biology, MD and PhD in Genetics, and currently serves as Associate Clinical Professor at Yale University and Adjunct Professor at Sigros Hospital, University of Athens.
Roy Geronemus, MD
Faculty / Panelist
Dr. Geronemus is a board-certified cosmetic dermatologist, serving as the Director of the Laser & Skin Surgery Center of New York and Clinical Professor of Dermatology at New York University Medical Center, where he founded its laser program and served nine years as Chief of Dermatologic and Laser Surgery.
Faculty / Panelist
Dr. Geronemus is a board-certified cosmetic dermatologist, serving as the Director of the Laser & Skin Surgery Center of New York and Clinical Professor of Dermatology at New York University Medical Center, where he founded its laser program and served nine years as Chief of Dermatologic and Laser Surgery.
David Ozog, MD
Faculty / Panelist
Dr. Ozog is a board-certified dermatologist and serves as Chair of the Department of Dermatology at Henry Ford Hospital in Detroit, Michigan, and is an active Mohs surgeon and Director of Cosmetic Dermatology.
Faculty / Panelist
Dr. Ozog is a board-certified dermatologist and serves as Chair of the Department of Dermatology at Henry Ford Hospital in Detroit, Michigan, and is an active Mohs surgeon and Director of Cosmetic Dermatology.
Elizabeth Tanzi, MD
Faculty / Panelist
Dr. Tanzi is a board-certified dermatologist. She is the Founder and Director of Capital Laser and Skin Care in metro Washington, DC and is an Associate Clinical Professor of Dermatology at George Washington University School of Medicine.
Faculty / Panelist
Dr. Tanzi is a board-certified dermatologist. She is the Founder and Director of Capital Laser and Skin Care in metro Washington, DC and is an Associate Clinical Professor of Dermatology at George Washington University School of Medicine.
Copyright © 2023, ASDS. Copy and distributing content in print or any electronic forms without written permission from ASDS is strictly prohibited.
